Challenges in the development and establishment of exosome-based drug delivery systems

被引:214
|
作者
Wang, Jin [1 ]
Chen, Derek [1 ]
Ho, Emmanuel A. [1 ,2 ]
机构
[1] Univ Waterloo, Sch Pharm, Kitchener, ON, Canada
[2] Waterloo Inst Nanotechnol, Waterloo, ON, Canada
基金
加拿大健康研究院;
关键词
Exosomes; Extracellular vesicles; Nanoparticles/nanomedicines; Drug delivery; NANOPARTICLE TRACKING ANALYSIS; MILK-DERIVED EXOSOMES; EXTRACELLULAR VESICLES; CELLULAR UPTAKE; IN-VITRO; CULTURE SUPERNATANT; CEREBRAL-ISCHEMIA; FLOW-CYTOMETRY; HUMAN SALIVA; PACLITAXEL;
D O I
10.1016/j.jconrel.2020.10.020
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Exosomes are extracellular vesicles released from cells and are characterized by a lipid bilayer membrane encapsulating a variety of biological molecules such as nucleic acids or proteins within the lumen or the lipid-bilayer. Under physiological environments, exosomes mediate cell-to-cell communication and cargo transport. Therefore, exosomes have been explored as drug delivery vehicles for improving therapeutic outcomes. Although recent studies have demonstrated promising advances with exosome-based drug delivery systems, several challenges severely hinder further development of exosomes for clinical applications. This review summarizes and emphasizes some of the technical challenges related to the isolation, characterization, and stability testing of exosomes. More importantly, challenges related specifically to the application of exosomes for drug delivery such as cell-uptake, drug loading, drug release, and in vivo distribution will be examined in this article.
引用
收藏
页码:894 / 906
页数:13
相关论文
共 50 条
  • [21] Exosome-based liquid biopsies in cancer: opportunities and challenges
    Yu, W.
    Hurley, J.
    Roberts, D.
    Chakrabortty, S. K.
    Enderle, D.
    Noerholm, M.
    Breakefield, X. O.
    Skog, J. K.
    ANNALS OF ONCOLOGY, 2021, 32 (04) : 466 - 477
  • [22] Development and regulation of exosome-based therapy products
    Batrakova, Elena V.
    Kim, Myung Soo
    WILEY INTERDISCIPLINARY REVIEWS-NANOMEDICINE AND NANOBIOTECHNOLOGY, 2016, 8 (05) : 744 - 757
  • [23] Development of Exosome-Based Biomarkers for Manganese Neurotoxicity
    Manne, S.
    Kondru, N.
    Jin, H.
    Lee, E. Y.
    Lewis, M.
    Anantharam, V.
    Huang, X.
    Kanthasamy, A.
    Kanthasamy, A.
    INTERNATIONAL JOURNAL OF TOXICOLOGY, 2020, 39 (01) : 55 - 55
  • [24] Exosome-based immunotherapy
    Chaput, N
    Taïeb, J
    Schartz, NEC
    André, F
    Angevin, E
    Zitvogel, L
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2004, 53 (03) : 234 - 239
  • [25] Techniques and Applications of Animal- and Plant-Derived Exosome-Based Drug Delivery System
    Man, Fulong
    Wang, Junfeng
    Lu, Rong
    JOURNAL OF BIOMEDICAL NANOTECHNOLOGY, 2020, 16 (11) : 1543 - 1569
  • [26] Exosome-based immunotherapy
    Nathalie Chaput
    Julien Taïeb
    Noël E. C. Schartz
    Fabrice André
    Eric Angevin
    Laurence Zitvogel
    Cancer Immunology, Immunotherapy, 2004, 53 : 234 - 239
  • [27] Advances in Exosome-Based Drug Delivery and Tumor Targeting: From Tissue Distribution to Intracellular Fate
    Shao, Juntang
    Zaro, Jennica
    Shen, Yuxian
    INTERNATIONAL JOURNAL OF NANOMEDICINE, 2020, 15 : 9355 - 9371
  • [28] Exosome-based delivery of RNAi leads to breast cancer inhibition
    Silva, Renata
    Ferreira, Debora
    Rodrigues, Ligia R.
    JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY, 2022, 78
  • [29] Targeting Tetraspanins at Cell Interfaces: Functional Modulation and Exosome-Based Drug Delivery for Precise Disease Treatment
    Xu, Kun
    Feng, Huixia
    Zhao, Rui
    Huang, Yanyan
    CHEMMEDCHEM, 2025, 20 (02)
  • [30] ExoDS: a versatile exosome-based drug delivery platform to target cancer cells and cancer stem cells
    Paul, Swastika
    Bhagat, Shrikrishna
    Dash, Lipsa
    Mohapatra, Himadri Das
    Jena, Sarita
    Verma, Suresh K.
    Dutta, Abhishek
    FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY, 2024, 12